Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brian Betensky

Clinical Cardiac Electrophysiology Sarasota, FL Medical Doctor

NPI 1851553481 CMS profile 84670

1950 Arlington St, Suite 400, Sarasota, FL 34239

Open in the dashboard

General payments

$411,563

971 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$204,718 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Brian Betensky of Sarasota, FL is reported in the CMS Open Payments database as having received $411,563 across 971 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $204,718 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $119,183 260
2024 General $70,965 149
2023 General $57,944 111
2022 General $49,508 110
2021 General $32,683 112
2020 General $39,579 95
2019 General $41,701 134

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brian Betensky
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Brian Betensky were reported at $119,183. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Brian Betensky Clinical Cardiac Electrophysiology median Middle half National median
2019 $41,701 $2,361 $585–$8,260 $163
2020 $39,579 $993 $247–$4,351 $114
2021 $32,683 $1,185 $326–$4,739 $132
2022 $49,508 $2,073 $554–$6,789 $149
2023 $57,944 $2,568 $759–$8,159 $160
2024 $70,965 $2,557 $703–$7,403 $164
2025 $119,183 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $114,476 233 payments
  2. Boston Scientific Corporation $93,178 163 payments
  3. Aziyo Biologics, Inc. $74,247 131 payments
  4. Medical Device Business Services, Inc. $56,700 18 payments
  5. Abbott Laboratories $35,437 67 payments
  6. Biosense Webster, Inc. $26,752 98 payments
  7. Cardiva Medical, Inc. $5,597 7 payments
  8. Janssen Pharmaceuticals, Inc $1,315 12 payments
  9. Medtronic, Inc. $1,223 80 payments
  10. Novartis Pharmaceuticals Corporation $524 37 payments
  11. Other $2,115 125 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $197,288 213 payments
  2. Consulting Fee $130,624 76 payments
  3. Honoraria $52,772 48 payments
  4. Food and Beverage $16,615 609 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $5,375 3 payments
  6. Travel and Lodging $4,621 17 payments
  7. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $4,200 4 payments
  8. Education $70 1 payment
Products named General payments · program years 2019–2025
  1. LifeVest $114,476 233 payments
  2. Carto 3 $82,327 68 payments
  3. ECM Patch,Pouch $74,184 129 payments
  4. General - EP $59,845 66 payments
  5. General - Brady $14,100 32 payments
  6. Ensite Cardiac Mapping System $12,700 14 payments
  7. Endurity Pacemaker $7,711 6 payments
  8. General Therapies $5,888 9 payments
  9. Cardiva VASCADE MVP VVCS 6-12F $5,546 6 payments
  10. General - Therapies $5,026 3 payments
  11. Other $29,745 412 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 35 drugs

Part D claims

3,257

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$1,111,689

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

33.5%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 626 $781,748
Farxiga Dapagliflozin Propanediol Brand 65 $74,926
Xarelto Rivaroxaban Brand 63 $68,460
Entresto Sacubitril/Valsartan Brand 51 $61,107
Multaq Dronedarone Hcl Brand 29 $50,791
Repatha Sureclick Evolocumab Brand 36 $24,532
Dofetilide Generic 25 $11,313
Metoprolol Succinate Generic 534 $8,039
Flecainide Acetate Generic 136 $5,979
Mexiletine Hcl Generic 43 $4,192

The 10 drugs with the highest cost, of 35 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 72 billing codes

Paid by Medicare

$1,343,769

Medicare's payments for the services billed

Medicare patients

2,643

Average age 78

Services billed

11,604

1,160 women, 1,483 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 66%
Ischemic heart disease 60%
Arthritis 58%
Heart failure 42%
Chronic kidney disease 33%
Diabetes 30%
Depression 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 9 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
LEQVIO
$147 — —
MULTAQ
$79 29 —
VYNDAQEL
$74 — —
Arcalyst
$31 — —
AMVUTTRA
$27 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 9 in the dashboard with a free account

Records

971 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record